Header Ads

Australian COVID-19 vaccine produces ZERO side effects in human trials and provides protection against the virus in animals while reducing symptoms

A coronavirus vaccine being developed by Australian researchers has produced zero side effects in human trials so far and has shown promise with mammals.
The University of Queensland and Australian biotech giant CSL last month began injecting 120 Brisbane volunteers with a trial vaccine.
Hamsters in the Netherlands were also administered the drug.
A coronavirus vaccine being developed by Australian researchers has produced zero side in trials on humans and animals. Pictured is a researcher at the University of Queensland
A coronavirus vaccine being developed by Australian researchers has produced zero side in trials on humans and animals. Pictured is a researcher at the University of Queensland

Project co-leader Associate Professor Keith Chappell said the European animal trials, conducted by Dutch diagnostic testing firm Viroclinics-DDL, had proven to be a success.
Project co-leader Associate Professor Keith Chappell said the European animal trials, conducted by Viroclinics-DDL, had proven to be a success
Project co-leader Associate Professor Keith Chappell said the European animal trials, conducted by Viroclinics-DDL, had proven to be a success
'The neutralising immune response created by our molecular clamp vaccine in animal models was better than the average level of antibodies found in patients who have recovered from COVID-19,' Dr Chappell said. 
He said the hamsters given the vaccine and Seqirus MF59® adjuvant had reduced lung inflammation after exposure to the virus.
No side effects have been reported so far on the human trial element taking place in Brisbane, although more clinical results are needed from the volunteers in suburban Herston.
UQ's Brisbane project is one of just 17 human trials for a potential vaccine happening worldwide, including in the US, UK and China.
Globally, more than 130 coronavirus vaccines are being developed but UQ's work has demonstrated great success in the pre-clinical development stage.
The good news from clinical trials has been revealed a week after Prime Minister Scott Morrison's government signed an in-principal deal with UK pharmaceutical giant AstraZeneca to receive early supplies of a potentially successful vaccine being developed with Oxford University.
UQ is running clinical trials until mid-2021 - but, if successful, a potential vaccine could be rolled out at the start of next year for emergency use among the broader Australian population. Pictured is a woman in Melbourne wearing a face mask on Swanston Street during this month's Stage 4 lockdown
UQ is running clinical trials until mid-2021 - but, if successful, a potential vaccine could be rolled out at the start of next year for emergency use among the broader Australian population. Pictured is a woman in Melbourne wearing a face mask on Swanston Street during this month's Stage 4 lockdown
Should UQ successfully develop a vaccine in Australia, Dr Chappell said the biggest challenge would be in tasking CSL, formerly known as Commonwealth Serum Laboratories, with manufacturing sufficient quantities of the drug.
'One of the big challenges in the development of vaccines is the ability to produce them at sufficient scale for widespread use,' he said.
'We are working with CSL to ensure the production yield is as efficient as possible, and have every confidence they will be able to manufacture the millions of doses required to protect the Australian public.'
UQ is running clinical trials until mid-2021 - but, if successful, a potential vaccine could be rolled out at the start of next year for emergency use among the broader Australian population.
Should UQ successfully develop a vaccine in Australia, the biggest challenge would be in tasking CSL, formerly known as Commonwealth Serum Laboratories, with manufacturing sufficient quantities of the drug
Should UQ successfully develop a vaccine in Australia, the biggest challenge would be in tasking CSL, formerly known as Commonwealth Serum Laboratories, with manufacturing sufficient quantities of the drug
The University of Queensland and biotech giant CSL last month began injecting 120 Brisbane volunteers with a trial vaccine. Pictured is Queensland Premier Annastacia Palaszczuk announcing the program. Her government has provided $10million to the project
The University of Queensland and biotech giant CSL last month began injecting 120 Brisbane volunteers with a trial vaccine. Pictured is Queensland Premier Annastacia Palaszczuk announcing the program. Her government has provided $10million to the project
Scott Morrison aims for 95% vaccination rate across Australia
Loaded: 0%
Progress: 0%
0:00
Previous
Play
Skip
Mute
Current Time0:00
/
Duration Time1:37
Fullscreen
Need Text
The Queensland vaccine has the advantage of being worked on in partnership with a manufacturer, CSL, meaning it could be mass produced quickly if successful.
The global Coalition for Epidemic Preparedness announced a partnership with CSL in June to fast-track clinical testing and potentially begin manufacturing should the trials prove successful.
CEPI gave UQ $15.16million to develop a molecular clamp vaccine platform that enables rapid vaccine design and production. 
Another $10million came from the Queensland government, with the commonwealth chipping in another $5million in addition to the $10million that has come from philanthropic donors.

3 comments:

  1. The government and the medical e$tabli$hment are telling you that you all can trust us and there will never, ever be side effects. Now, don't you feel 100% satisfied with that knowledge?

    ReplyDelete
  2. ZERO side effects?
    How about long term side effects?
    How about side effects based on other prescribed drugs?
    How about double-blind, placebo controlled clinical trials over months? THE GOLD STANDARD for safety and efficacy?

    No, just shoot up some willing candidates and after 20 minutes, manipulate the outcome to suit your pre-determined objective. C'mon man, there's billions of dollars at stake here!!!

    ReplyDelete
    Replies
    1. No side effects so far, what is the side effects of getting covid19? Patients who were in intensive care for COVID-19 may have long-term pulmonary damage.

      Delete